CLEARANCE FROM DIALYSATE AND EQUILIBRATION OF INTRAPERITONEAL VANCOMYCIN IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS

被引:15
|
作者
NEAL, D
BAILIE, GR
机构
[1] ALBANY COLL PHARM,106 NEW SCOTLAND AVE,ALBANY,NY 12208
[2] UNIV MANCHESTER,DEPT PHARM,MANCHESTER M13 9PL,LANCS,ENGLAND
关键词
D O I
10.2165/00003088-199018060-00005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article reports on a study of the disposition of loading doses (1g and 15 mg/kg) of vancomycin given intraperitoneally to 6 patients on continuous ambulatory peritoneal dialysis with Gram-positive peritonitis. Dialysate samples were collected every 30 minutes during the first dwell, and serum samples were collected after the first 5 exchanges and after 7 or 14 days. The dialysate concentration/time data were fitted to a monoexponential curve for 4 patients and to a biexponential curve for 2 others. Dialysis clearance was 0.73 ± 0.04 L/h (1g dose) and 0.70 ± 0.23 L/h (15 mg/kg dose). Total body clearance was 0.51 ± 0.36 L/h. Serum concentrations reached 14 to 18 mg/L (15 mg/kg dose) and 6.75 to 24 mg/L (1g dose) at the end of the first dwell. The half-life of equilibration of vancomycin across the peritoneal membrane was 2.5 ± 2.3 hours. Intraperitoneal loading doses of vancomycin produce concomitant serum concentrations in excess of the minimum inhibitory concentrations for susceptible organisms. Administration on a milligram per kilogram basis produces more consistent serum concentrations than using a standard loading dose which is not based on bodyweight. © 1990, Adis Press Limited. All rights reserved.
引用
收藏
页码:485 / 490
页数:6
相关论文
共 50 条
  • [1] INTRAPERITONEAL INSULIN IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    RIAMBAU, E
    AUBIA, J
    LLORACH, I
    LLOVERAS, J
    MASRAMON, J
    ORFILA, MA
    LLORACH, M
    [J]. REVISTA CLINICA ESPANOLA, 1982, 164 (05): : 333 - 334
  • [2] PERITONEAL-DIALYSIS CLEARANCE OF TOCAINIDE IN A PATIENT ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    BRAUN, J
    SORGEL, F
    ENGELMAIER, F
    GESSLER, U
    [J]. PERITONEAL DIALYSIS BULLETIN, 1985, 5 (02): : 139 - 139
  • [3] SERUM AND DIALYSATE CONCENTRATIONS OF INTRAPERITONEAL CEPHALOTHIN IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    MUNCH, R
    STEURER, J
    LUTHY, R
    SIEGENTHALER, W
    KUHLMANN, U
    [J]. CLINICAL NEPHROLOGY, 1983, 20 (01) : 40 - 43
  • [4] INFLUENCE OF INTRAPERITONEAL DIALYSATE ON BLOOD-PRESSURE DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    FLEMING, SJ
    POWELL, J
    BAKER, LRI
    CATTELL, WR
    GREENWOOD, R
    [J]. CLINICAL NEPHROLOGY, 1983, 19 (03) : 132 - 133
  • [5] AN EVALUATION OF THE DIALYSATE SOLUTIONS FOR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    LAMEIRE, N
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1987, 30 (5-6): : 301 - 307
  • [6] PERITONITIS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS - A ROLE FOR THE DIALYSATE
    MARICHAL, JF
    FALLER, B
    BRIGNON, P
    DEGOULET, P
    AIME, F
    [J]. NEPHRON, 1986, 42 (02) : 167 - 170
  • [7] PHENYTOIN CLEARANCE BY CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    HAYS, DP
    PRIMACK, WA
    ABROMS, IF
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 429 - 431
  • [8] PHARMACOKINETICS OF INTRAPERITONEAL MOXALACTAM IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    MORSE, GD
    JANICKE, DM
    CAFARELL, RF
    WALSHE, JJ
    VENUTO, RC
    APICELLA, MA
    JUSKO, WJ
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 493 - 493
  • [9] PHARMACOKINETICS OF VANCOMYCIN DURING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    MATZKE, GR
    HALSTENSON, CE
    BLEVINS, RB
    SALEM, NG
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 236 - 236
  • [10] INTRAPERITONEAL PRODUCTION OF ERYTHROPOIETIN WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    CHANDRA, M
    CLEMONS, G
    SAHDEV, I
    MCVICAR, M
    BLUESTONE, P
    [J]. PEDIATRIC NEPHROLOGY, 1993, 7 (03) : 281 - 283